NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Tommy Weiss‐Sadan(Massachusetts General Hospital), Liron Bar‐Peled(Harvard University), Stefan Harry(Massachusetts General Hospital), Lei Shi(Broad Institute), Makiko Hayashi(NYU Langone Health), Konstantin Wolf(Massachusetts General Hospital), Magdy Gohar(Massachusetts General Hospital), Junbing Zhang(Massachusetts General Hospital), Ting-Yu Wei(Massachusetts General Hospital), Adriaan de Groot(Massachusetts General Hospital), Charles H. Adelmann(The University of Texas MD Anderson Cancer Center), Benedikt R. Dürr(Massachusetts General Hospital), Marianne Richter(Massachusetts General Hospital), Marcia C. Haigis(Harvard University), Mariko Takahashi(Massachusetts General Hospital), Maolin Ge(Shanghai Jiao Tong University), Cong-Hui Yao(Washington University in St. Louis), Tristan Vornbäumen(Massachusetts General Hospital), Thales Papagiannakopoulos(NYU Langone Health), Vindhya Vijay(Broad Institute), Raúl Mostoslavsky(Massachusetts General Hospital), Alexander Carlin(Massachusetts General Hospital), David E. Fisher(Dana-Farber Cancer Institute), Aaron N. Hata(Harvard University), Hannah Fischer(Massachusetts General Hospital), Nabeel Bardeesy(Broad Institute), Tzu-yi Yang(Massachusetts General Hospital)
Cited by 142
Related Papers
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938